• OPEN AN ACCOUNT
Indian Indices
Nifty
26,046.95 148.40
(0.57%)
Sensex
85,267.66 449.53
( 0.53%)
Bank Nifty
59,389.95 180.10
( 0.30%)
Nifty IT
38,274.75 177.75
( 0.47%)
Global Indices
Nasdaq
48,727.83 649.07
(1.35%)
Dow Jones
6,922.99 15.31
(0.22%)
Hang Seng
50,843.93 695.11
(1.39%)
Nikkei 225
9,710.82 55.29
(0.57%)
Forex
USD-INR
89.89 -0.04
(-0.04%)
EUR-INR
104.69 0.05
(0.05%)
GBP-INR
119.80 0.03
(0.03%)
JPY-INR
0.57 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Aristo Bio-Tech & Lifescience Ltd
Industry :  Pesticides / Agrochemicals - Indian
BSE Code
ISIN Demat
Book Value()
76744
INE082101010
54.8360704
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ARISTO
19.43
77.92
EPS(TTM)
Face Value()
Div & Yield %
5.89
10
0.44
 

IIFL Finance jumps after board clears Rs 2,000-cr fundraising proposal
Nov 26,2025
The company will issue secured, rated, listed, redeemable non-convertible debentures (NCDs), including green shoe option in one or more tranches.

IIFL Finance is a middle layer non-banking financial company (NBFC) not accepting public deposits registered with the Reserve Bank of India (the RBI) and primarily engaged in financing and related activities. The company offers a broad suite of financial products and deals majorly into loans such as gold loan, loans to Micro, small & medium enterprise (MSME), loan against securities and digital finance loans.

The company reported a consolidated net profit of Rs 376.33 crore in Q2 FY26 compared with net loss of Rs 157.67 crore in Q2 FY25. Total income jumped 29.2% YoY to Rs 3,309.16 crore in Q2 FY26.